Skip to content

Deferred income at other companies

MPLX logo
MPLXMPLX
$115M-63.7%
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$177M+167%
Williams Companies logo
Williams CompaniesWMB
$170M+6.9%
UnitedHealth Group logo
UnitedHealth GroupUNH
$3.42B+3.7%
Moody's logo
Moody'sMCO
$54M-5.3%
Arthur J. Gallagher logo
Arthur J. GallagherAJG
$809M+28.6%

Other financials

Income statement

See full
Revenue$115.2M+44.9%
Gross profit$30.1M+267%
Operating income-$310.4M-560%
Net income-$347.2M-160%
EPS (diluted)-$1.06-185%

Balance sheet

See full
Cash & equivalents$1.1B+64.0%
Total debt$2.2B+82.8%
Total equity-$1.3B-323%
Total assets$3.1B+88.9%

Cash flow

See full
Operating cash flow$249.9M+655%
CapEx$389.2M+363%
Free cash flow-$139.3M-8.0%

Valuation

See full
Market cap$9.27B+121%
Enterprise value$10.28B+119%
P/S26.1×+15.9×

Profitability

See full
Gross margin16.9%+4.3pp
Operating margin-144.7%-478pp
Net margin-238.9%-1.8pp
FCF margin-130%-246pp

Returns & leverage

See full
Return on equity-242.4%
Debt / equity2.2×
Current ratio0.5×-3.7×

Where this comes from

Reported directly by Core Scientific, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredRevenueNoncurrent.

The official record: Core Scientific, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Scientific, Inc.'s deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Scientific, Inc.'s deferred income?
Core Scientific, Inc. (CORZ) reported deferred income of $434.67M in Q1 2026.